MicroRNA-133a inhibits osteosarcoma cells proliferation and invasion via targeting IGF-1R

Cellular Physiology and Biochemistry

Volumn 38, Issue 2, 2016, Pages 598-608

  Chen, Guangnan ^a   Fang, Tingting ^b   Huang, Zhongming ^c   Qi, Yiying ^a   Du, Shaohua ^a   Di, Tuoyu ^a   Lei, Zhong ^a   Zhang, Xiangyu ^a   Yan, Weiqi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c Xiaoshan Traditional Chinese Medical Hospital   (China)

Author keywords

ERK AKT signaling pathway; IGF 1R; MicroRNA; MicroRNA 133a; Osteosarcoma

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 133A; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; IGF1R PROTEIN, HUMAN; MIRN133 MICRORNA, HUMAN; SOMATOMEDIN RECEPTOR;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; BONE; BONE TUMOR; CELL MOTION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BONE AND BONES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEOSARCOMA; RECEPTORS, SOMATOMEDIN;

EID: 84957674540     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438653     Document Type: Article

References (34)

1. Ottaviani G, Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res 2009;152:3-13.
2. Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y: The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 2004:165-172.
3. Gupta A, Meswania J, Pollock R, Cannon SR, Briggs TW, Taylor S, Blunn G: Non-invasive distal femoral expandable endoprosthesis for limb-salvage surgery in paediatric tumours. J Bone Joint Surg Br 2006;88:649-654.
4. Ebert MS, Sharp PA: Roles for microRNAs in conferring robustness to biological processes. Cell 2012;149:515-524.
5. Hayes J, Peruzzi PP, Lawler S: MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol Med 2014;20:460-469.
6. Rogers K, Chen X: Biogenesis, turnover, and mode of action of plant microRNAs. Plant Cell 2013;25:2383-2399.
7. Huntzinger E, Izaurralde E: Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat Rev Genet 2011;12:99-110.
8. Cho WC: MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010;42:1273-1281.
9. Mendell JT, Olson EN: MicroRNAs in stress signaling and human disease. Cell 2012;148:1172-1187.
10. Callegari E, Gramantieri L, Domenicali M, D'Abundo L, Sabbioni S, Negrini M: MicroRNAs in liver cancer: A model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ 2015;22:46-57.
11. Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, Wang C, Ren Z, Zhao Y, Wu S, Zhuang R, Zhang Y, Hu H, Liu C, Xu L, Wang J, Shen H, Zhang J, Zen K, Zhang CY: Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2012;130:1620-1628.
12. Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E: Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. Clin Chem 2014;60:197-205.
13. Miao J, Wu S, Peng Z, Tania M, Zhang C: MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects. Tumour Biol 2013;34:2093-2098.
14. Chen B, Huang Z, Zhang Y, Chen Y, Li Z: MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16. Cell Physiol Biochem 2015;37:2183-2193.
15. Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M, Quan ZX, Chen J: MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4. Cell Physiol Biochem 2014;34:2180-2188.
16. Pan W, Wang H, Jianwei R, Ye Z: MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem 2014;33:402-412.
17. Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F: MicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 2010;24:1363-1369.
18. Bertrand FE, Steelman LS, Chappell WH, Abrams SL, Shelton JG, White ER, Ludwig DL, McCubrey JA: Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells. Leukemia 2006;20:1254-1260.
19. Estan MC, Calvino E, de Blas E, Boyano-Adanez MC, Mena ML, Gomez-Gomez M, Rial E, Aller P: 2-Deoxy- D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: Involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways. Biochem Pharmacol 2012;84:1604-1616.
20. Shelton JG, Steelman LS, White ER, McCubrey JA: Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells. Cell Cycle 2004;3:372-379.
21. Wang LK, Hsiao TH, Hong TM, Chen HY, Kao SH, Wang WL, Yu SL, Lin CW, Yang PC: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. Plos One 2014;9:e96765.
22. Xu XC, Zhang YH, Zhang WB, Li T, Gao H, Wang YH: MicroRNA-133a functions as a tumor suppressor in gastric cancer. J Biol Regul Homeost Agents 2014;28:615-624.
23. Zheng K, Liu W, Liu Y, Jiang C, Qian Q: MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1. Oncol Lett 2015;9:869-874.
24. Akanuma N, Hoshino I, Akutsu Y, Murakami K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M, Suito H, Hu X, Sekino N, Matsubara H: MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer 2014;110:189-198.
25. Luo J, Zhou J, Cheng Q, Zhou C, Ding Z: Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncol Lett 2014;7:1043-1048.
26. Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, Wang Z, Wang Z, Cheng P, Tong D, Li C, Tang H: MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 2013;56:220-226.
27. Fujiwara T, Katsuda T, Hagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T, Ichikawa H, Yoshida A, Kobayashi E, Kawai A, Ozaki T, Ochiya T: Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells 2014;32:959-973.
28. LeRoith D, Werner H, Neuenschwander S, Kalebic T, Helman LJ: The role of the insulin-like growth factor-I receptor in cancer. Ann N Y Acad Sci 1995;766:402-408.
29. Li S, Ferber A, Miura M, Baserga R: Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J Biol Chem 1994;269:32558-32564.
30. Hutchinson L: Lung cancer: Combating resistance through IGF-1R and ALK co-targeting. Nat Rev Clin Oncol 2014;11:622.
31. Kirschner LS: Inhibition of IGF-1R in adrenocortical carcinoma. Lancet Oncol 2015;16:356-357.
32. Liang J, Li B, Yuan L, Ye Z: Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: A meta-analysis. Onco Targets Ther 2015;8:1949-1955.
33. Zhang W, Liu K, Liu S, Ji B, Wang Y, Liu Y: MicroRNA-133a functions as a tumor suppressor by targeting IGF- 1R in hepatocellular carcinoma. Tumour Biol 2015;36:9779-9788.
34. Gong Y, Ren J, Liu K, Tang LM: Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. World J Gastroenterol 2015;21:2949-2958.